期刊文献+

急性重症胆管炎患者LDH、ALT、血小板及凝血功能测定的意义 被引量:2

LDH,platelet and coagulation changes in acute severe cholangitis patients
暂未订购
导出
摘要 目的探讨急性重症胆管炎(ACST)乳酸脱氢酶(LDH)、血小板(PLT)与凝血功能之间的关系。方法对急诊入院的42例ACST患者立刻采血,分别测定LDH、PLT、血浆纤维蛋白原(Fib)、血管性血友病因子(vWF)、纤维蛋白A肽(FPA)、血小板a颗粒膜蛋白-140(GMP-140)、抗凝血酶-Ⅲ(AT-Ⅲ)含量,并与正常对照组比较。结果与正常对照组比较,重症胆管炎患者LDH、vWF、GMP-140、FPA显著增高(P<0.05),PLT、AT-Ⅲ则显著降低(P<0.05),而Fib无显著差异(P>0.05)。结论重症胆管炎患者存在明显的组织损伤和凝血、抗凝血系统的功能紊乱,通过对ACST患者LDH、PLT及凝血功能的观察,可作为了解ACST病情严重程度和预后评估的客观指标。 Objective To observe the clinical significance of lactic dehydrogenase (LDH), platelet and coagulation changes in acute severe cholangitis patients. Methods LDH , Platelet, fibrinogen ( Fib), van Willebrand factor (vWF), fibinopeptide A, platdet granulate membrane protein-140 (GMP-140) and antithrombin-Ⅲ (AT-Ⅲ) were measured in 42 consecutive patients suffering from acute severe cholangitis after emergency admission. Results All the patients showed an increase in LDH, GMP-140, vWF and FPA activity accompanied a significant decrease in PLT and AT-Ⅲ and there was no marked changes in Fib in patients with acute severe eholangitis. Conclusions There is a significant coagulation disorder in patients with acute severe cholangitis. Understand serious degree and post-assessment objective index through exploration for LDH, PLT and coagulation changes in patients suffered from ACST.
作者 菅凤国
出处 《中国实用医药》 2008年第27期13-14,共2页 China Practical Medicine
关键词 急性重症胆管炎 乳酸脱氢酶 血小板 凝血 Acute severe cholangitis Lactic dehydrogenase Platelet Coagulation
  • 相关文献

参考文献4

二级参考文献25

  • 1黄志强.肝胆管结石专题讨论会纪要[J].中华外科杂志,1983,21(6):372-372.
  • 2黄志强.努力提高对重症急性胆管炎的治疗效果[J].实用外科杂志,1986,6(1):1-1.
  • 3詹贤望 曹登科 等.胆汁细菌计数与老年胆道疾病的关系[J].中国普通外科杂志,1999,8:2-22.
  • 4陈灏珠 主编.内科学第4版[M].北京:人民卫生出版社,1996.651.
  • 5Mohri M,Suzuki M,Sugimoto E,et al.Effects of recombinant human soluble thrombomodulin(rhs-TM) on clot-induced coagulation in human plasma.Thromb Haemost,1998,80:925-929.
  • 6Aoki Y,Ohishi R,Takei R,et al.Effects of recombinant human soluble thrombomodulin(rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin Ⅲ.Thromb Haemost,1994,71:452-455.
  • 7Creasey AA,Chang ACK,Feigen L,et al.Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.J Clin Invest,1993,91:2850-2860.
  • 8Pajkrt D,van der Poll T,Levi M,et al. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxmia .Blood,1997,89:2701-2705.
  • 9Mammen EF. Disseminated intravascular coagulation(DIC).Clin lab Sci,2000,13:239-245.
  • 10Toh CH,Dennis M. Disseminated intravascular coagulation: old disease,new hope.BMJ,2003,327:974-977.

共引文献24

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部